ENHERTU approved in the US for two new indications for patients with HER2-positive early Breast...

CDSCO approves Astellas’ PADCEV for first-line advanced Bladder cancer treatment

PADCEV in combination with Keytruda receives positive CHMP opinion for the treatment of patients with...

TroFuse-005 trial evaluating Sacituzumab Tirumotecan met primary endpoints of OS and PFS in certain patients...

Hengrui announces phase 3 trial of HER3 ADC SHR-A2009 for EGFR-mutant advanced NSCLC met primary...

Kelun-Biotech announces phase 3 trial of Sacituzumab Tirumotecan versus Chemotherapy as 1L treatment for advanced...